poursina hakim digestive diseases research center

Cancer Articles 2020

18 تیر 1403 20 Views No Comments

TiO2 nanotubes/reduced GO nanoparticles for sensitive detection of breast cancer cells and photothermal performance

Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry

Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients

A histopathological image dataset for grading breast invasive ductal carcinomas

Androgen Receptor Expression and Its Correlation with Clinicopathological Parameters in Iranian Patients with Triple Negative Breast Cancer

Related Posts
Extracellular vesicles: unlocking therapeutic potential in regenerative medicine

Extracellular vesicles: unlocking therapeutic potential in regenerative medicine

 18 آذر 1403
Exercise and Magnesium Sulfate Improve Infertility Caused by Lithium Carbonate in Male Rats

Do Exercise and Magnesium Sulfate Improve Infertility Caused by Lithium Carbonate in Male Rats?

 11 آذر 1403

Metabolic Disorders 2024

 4 آذر 1403
psychological Adaptation in the Patients with Irritable Bowel Syndrome

Model of Predicting Psychosocial Adaptation to Disease According to Perceived Stress and Sense of Coherence with the Mediation Role of SelfCompassion in the Patients with Irritable Bowel Syndrome

 3 آذر 1403

FGID Articles 2024

 3 آذر 1403
pan-cancer

Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan‑cancer analysis

 3 آذر 1403
The Prevalence of PD‑L1 Expression in Triple‑Negative Breast Cancer Patients and Its Correlation with Survival Rates and Other Prognostic Factors

The Prevalence of PD‑L1 Expression in Triple‑Negative Breast Cancer Patients and Its Correlation with Survival Rates and Other Prognostic Factors: A Survival Analysis

 26 آبان 1403
capacity of differentiated PD‑L1 CAR‑modified UCB‑CD34+ cells and PD‑L1 CAR‑modified UCB‑CD34+‑derived NK cells in killing target cells

Strong capacity of differentiated PD‑L1 CAR‑modified UCB‑CD34+ cells and PD‑L1 CAR‑modified UCB‑CD34+‑derived NK cells in killing target cells and restoration of the anti‑tumor function of PD‑1‑high exhausted T Cells

 26 آبان 1403
banner

Contact us

Contact Us

Email: pddrc.com@gmail.com

Phone: 09024265006

Quick access

Articles

Useful links

Poursina Hakim Holding Co

Masstec Medical Co

All site rights belong to Poursina Hakim Holding Co.

Available, you can order now!
Unavailable!
More product details